BSEBoard Meeting28 Sept 2026 · 28 Sept 2026, 03:20 pm
Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2026.
Medplus Health Services Ltd · 543427
✦ AI SummaryResults
Medplus Health Services Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 27/10/2026 to consider and approve the Un-audited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Medplus Health Services Ltd - 543427 - Board Meeting Intimation for The Quarter And Half-Year Ended September 30, 2026.
Attachments (1)
📄pdf
Download →
e0e3f028-c216-4980-b6b3-8ed57ff6a879.pdf
View document text
MedPlus Health Services Limited
September 28, 2026
The Listing Department The Listing Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza,
Dalal Street, Fort, Bandra Kurla Complex,
Mumbai 400 001 Bandra (East), Mumbai – 400 051
BSE Scrip Code Equity: 543427 NSE Symbol: MEDPLUS
Dear Sir/ Madam,
Sub: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 ("SEBI LODR ") and Trading Window Closure under SEBI
(Prohibition of Insider Trading) Regulations, 2015
Pursuant to Regulation 29 read with Regulation 33 of the SEBI LODR, we would like to inform that the
Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, October 27,
2026, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the
Company for the quarter and half-year ended September 30, 2026.
Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, and
Company’s Code of Conduct for Prevention of Insider Trading, the trading window for the Designated
Persons of the Company and including their immediate relatives, will be closed from October 01, 2026,
till 48 hours after declaration of Un-audited financial results of the Company for the quarter and half-
year ended September 30, 2026.
The same will be available on the website of the Company at www.medplusindia.com and also on the
websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and
www.nseindia.com respectively.
Kindly take the same on records.
Thanking You
Yours faithfully
For MedPlus Health Services Limited
Shrenik Soni
Company Secretary & Compliance Officer
ICSI M. No. F12400
040-6724 6724
Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India
CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com